“abl”的搜索结果

产品 51 到 100 共 176个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4

设置降序顺序
  1. L-Buthionine-(S,R)-sulfoximine

    Catalog No. A21895
    Quick View
    g-glutamylcysteine synthetase inhibitor
    L-Buthionine-(S,R)-sulfoximine is a cell-permeable, potent, fast acting and irreversible inhibitor of g-glutamylcysteine synthetase and depletes cellular glutathione levels. 了解更多
  2. TAK-659 hydrochloride

    Catalog No. A21885
    Quick View
    Syk inhibitor
    TAK-659 hydrochloride is a potent, selective and orally available spleen tyrosine kinase (Syk) inhibitor with an IC50 of 3.2 nM. 了解更多
  3. Tesevatinib

    Catalog No. A21875
    Quick View
    multi-target tyrosine kinase inhibitor
    Tesevatinib (XL-647; EXEL-7647; KD-019) is an orally available, multi-target tyrosine kinase inhibitor; inhibits EGFR, ErbB2, KDR, Flt4 and EphB4 kinase with IC50s of 0.3, 16, 1.5, 8.7, and 1.4 nM. 了解更多
  4. Cediranib maleate

    Catalog No. A21857
    Quick View
    VEGFR inhibitor
    Cediranib maleate (AZD-2171 maleate) is a highly potent, orally available VEGFR inhibitor with IC50s of <1, <3, 5, 5, 36, 2 nM for Flt1, KDR, Flt4, PDGFRα, PDGFRβ, c-Kit, respectively. 了解更多
  5. AZD5153 6-Hydroxy-2-naphthoic acid

    Catalog No. A21852
    Quick View
    BET/BRD4 bromodomain inhibitor
    AZD5153 6-Hydroxy-2-naphthoic acid is the 6-Hydroxy-2-naphthoic acid of AZD5153. AZD5153 is a potent, selective, and orally available BET/BRD4 bromodomain inhibitor; disrupts BRD4 with an IC50 of 1.7 nM. 了解更多
  6. DBPR108

    Catalog No. A21833
    Quick View
    DPP4 inhibitor
    DBPR108 is a potent, selective, and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM; no inhibition on DDP8 and DPP9. 了解更多
  7. RG7834

    Catalog No. A21816
    Quick View
    HBV inhibitor
    RG7834 (RO 7020322) is a highly selective and orally bioavailable HBV inhibitor, potently inhibits HBV antigens (both HBsAg and HBeAg) and HBV DNA, with IC50s of 2.8, 2.6, and 3.2 nM, respectively, in dHepaRG Cells. 了解更多
  8. CP-640186 hydrochloride

    Catalog No. A21808
    Quick View
    ACC inhibitor
    CP-640186 hydrochloride is a potent and cell-permeable Acetyl-CoA carboxylase (ACC) inhibitor with IC50s of 53 nM and 61 nM for rat liver ACC1 and rat skeletal muscle ACC2 respectively. 了解更多
  9. VP3.15 dihydrobromide

    Catalog No. A21789
    Quick View
    PDE7/GSK3 inhibitor
    VP3.15 dihydrobromide is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE)7- glycogen synthase kinase (GSK)3 inhibitor, with IC50s of 1.59 μM and 0.88 μM for PDE7 and GSK-3, respectively. 了解更多
  10. SHP099 hydrochloride

    Catalog No. A21762
    Quick View
    SHP2 inhibitor
    SHP099 hydrochloride is a potent, selective and orally available SHP2 inhibitor with an IC50 of 70 nM. 了解更多
  11. Tazemetostat hydrobromide

    Catalog No. A21759
    Quick View
    EZH2 inhibitor
    Tazemetostat hydrobromide (EPZ-6438 hydrobromide) is a potent, selective and orally available EZH2 inhibitor. 了解更多
  12. ML216

    Catalog No. A21754
    Quick View
    BLM helicase inhibitor
    ML216 (CID-49852229) is a potent, selective and cell permeable inhibitor of the DNA unwinding activity of BLM helicase with IC50s of 2.98 μM and 0.97 μM for BLMfull-length and BLM636-1298, respectively. 了解更多
  13. TAK-960 hydrochloride

    Catalog No. A21703
    Quick View
    PLK1 inhibitor
    TAK-960 hydrochloride is an orally available, selective inhibitor of polo-like kinase 1 (PLK1), with an IC50 of 0.8 nM at 10 μM ATP; TAK-960 hydrochloride also shows inhibitory activities against PLK2 and PLK3, with IC50s of 16.9 and 50.2 nM, respectively. 了解更多
  14. BMS-599626

    Catalog No. A21664
    Quick View
    HER1/HER2 inhibitor
    BMS-599626 (AC480) is a selective and orally bioavailable HER1 and HER2 inhibitor, with IC50s of 20 and 30 nM, respectively. 了解更多
  15. HS-10296 hydrochloride

    Catalog No. A21661
    Quick View
    EGFR/T790M inhibitor
    HS-10296 hydrochloride is an orally available and third-Generation inhibitor of epidermal growth factor receptor (EGFR)-activating mutations and T790M-resistant mutation with limited activity against wild-type EGFR. 了解更多
  16. HS80

    Catalog No. A21615
    Quick View
    FASN inhibitor
    HS-80 is an enantiomer of Fasnall, which is a selective fatty acid synthase (FASN) inhibitor. HS-80 is able to inhibit the incorporation of tritiated acetate into lipids with an IC50 of 7.13 μM. 了解更多
  17. Dutogliptin

    Catalog No. A21573
    Quick View
    DPP4 inhibitor
    Dutogliptin (PHX-1149 free base) is an orally available, potent, and selective dipeptidyl peptidase-4 (DPP4) inhibitor for the treatment of type 2 diabetes mellitus. 了解更多
  18. GDC-0575 dihydrochloride

    Catalog No. A21567
    Quick View
    CHK1 inhibitor
    GDC-0575 dihydrochloride (ARRY-575 dihydrochloride) is an orally bioavailable CHK1 inhibitor, with an IC50 of 1.2 nM, and has antitumor activity. 了解更多
  19. MK-0674

    Catalog No. A21558
    Quick View
    cathepsin K inhibitor
    MK-0674 is a potent, orally bioavailable and selective cathepsin K inhibitor, with an IC50 of 0.4 nM, shows 1156, 1465, 11857 and 243 fold selectivity over Cat B, Cat F, Cat L and Cat S. 了解更多
  20. Eniluracil

    Catalog No. A21548
    Quick View
    dihydropyrimidine dehydrogenase inhibitor
    Eniluracil (5-Ethynyluracil), a uracil analogue and a mechanism-based irreversible inhibitor of dihydropyrimidine dehydrogenase (DPD), increases the oral bioavailability of 5-fluorouracil (5-FU) to 100%, facilitating uniform absorption and predictable toxicity. 了解更多
  21. Genz-123346

    Catalog No. A21536
    Quick View
    glucosylceramide synthase inhibitor
    Genz-123346 is a potent, orally available glucosylceramide synthase inhibitor. 了解更多
  22. Amuvatinib hydrochloride

    Catalog No. A21503
    Quick View
    multi-targeted tyrosine kinase inhibitor
    Amuvatinib hydrochloride (MP470 hydrochloride) is an orally bioavailable multi-targeted tyrosine kinase inhibitor with potent activity against mutant c-Kit, PDGFRα, Flt3, c-Met and c-Ret. 了解更多
  23. AS601245

    Catalog No. A21502
    Quick View
    cell-permeable JNK Inhibitor
    AS601245 is a cell-permeable JNK Inhibitor with IC50s of 150, 220, and 70 nM for three JNK human isoforms (hJNK1, hJNK2, and hJNK3), respectively. 了解更多
  24. CVT-12012

    Catalog No. A21447
    Quick View
    SCD inhibitor
    CVT-12012 is a potent and orally bioavailable stearoyl-coA desaturase (SCD) inhibitor, with IC50s of 38 nM, 6.1 nM for rat microsomal and human HEPG2, respectively. 了解更多
  25. Raphin1 acetate

    Catalog No. A21373
    Quick View
    PPP1R15B inhibitor
    Raphin1 acetate is an orally bioavailable, selective inhibitor of the regulatory phosphatase PPP1R15B (R15B). 了解更多
  26. HDAC-IN-7

    Catalog No. A21252
    Quick View
    HDAC1/2/3/10 inhibitor
    HDAC-IN-7 (Chidamide impurity) is an impurity of Chidamide. Chidamide is a potent and orally bioavailable HDAC enzymes class I (HDAC1/2/3) and class IIb (HDAC10) inhibitor. 了解更多
  27. Indibulin

    Catalog No. A21210
    Quick View
    Tubulin assembly
    Indibulin (ZIO 301), an orally applicable inhibitor of tubulin assembly, shows potent anticancer activity with a minimal neurotoxicity. 了解更多
  28. MDR-1339

    Catalog No. A21138
    Quick View
    Aβ-aggregation inhibitor
    MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable Aβ-aggregation inhibitor, used in the research of Alzheimer's disease. 了解更多
  29. CCT241736

    Catalog No. A21097
    Quick View
    dual FLT3/Aurora kinase inhibitor
    CCT241736 is a potent and orally bioavailable dual FLT3 and Aurora kinase inhibitor. 了解更多
  30. Galidesivir hydrochloride

    Catalog No. A20930
    Quick View
    RdRp inhibitor
    Galidesivir hydrochloride (BCX 4430 hydrochloride) is a viral RNA-dependent RNA polymerase (RdRp) inhibitor; demonstrated broad-spectrum activity in multiple viruses and a favorable preliminary preclinical safety profile. 了解更多
  31. GDC-0339

    Catalog No. A20920
    Quick View
    Pim kinase inhibitor
    GDC-0339 is a potent, orally bioavailable and well tolerated pan-Pim kinase inhibitor, with Kis of 0.03 nM, 0.1 nM and 0.02 nM for Pim1, Pim2 and Pim3, respectively. GDC-0339 is discovered as a potential treatment of multiple myeloma. 了解更多
  32. Forodesine

    Catalog No. A20903
    Quick View
    PNP inhibitor
    Forodesine(BCX-1777 freebase; Immucillin-H) is an orally bioavailable PNP inhibitor with picomolar potency; induces apoptosis, mainly in T cells. 了解更多
  33. LTV-1

    Catalog No. A20901
    Quick View
    LYP inhibitor
    LTV-1 is a highly potent, cell-permeable and reversible inhibitor of lymphoid tyrosine phosphatase (LYP) (IC50 = 508 nM). 了解更多
  34. Voxelotor

    Catalog No. A20863
    Quick View
    HbS polymerization inhibitor
    Voxelotor (GBT 440) is an orally bioavailable sickle hemoglobin (HbS) polymerization inhibitor. 了解更多
  35. Edasalonexent

    Catalog No. A20853
    Quick View
    NF-κB inhibitor
    Edasalonexent (CAT-1004) is an orally bioavailable NF-κB inhibitor. 了解更多
  36. BAMB-4

    Catalog No. A20842
    Quick View
    ITPKA inhibitor
    BAMB-4(ITPKA-IN-C14) is a new membrane-permeable inhibitor against inositol-1,4,5-trisphosphate-3-kinase A((ITPKA) with IC50 of 37 μM in ADP-Glo Assay. 了解更多
  37. Niraparib hydrochloride

    Catalog No. A18018
    Quick View
    PARP1 and PARP2 inhibitor
    Niraparib hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. 了解更多
  38. Alectinib Hydrochloride

    Catalog No. A18000
    Quick View
    ALK inhibitor
    Alectinib Hydrochloride (CH5424802 Hydrochloride; RO5424802 Hydrochloride; AF-802 Hydrochloride) is a potent, selective, and orally available ALK inhibitor with an IC50 of 1.9 nM and a Kd value of 2.4 nM (in an ATP-competitive manner), and also inhibits ALK F1174L and ALK R1275Q with IC50s of 1 nM and 3.5 nM, respectively. 了解更多
  39. Apatinib

    Catalog No. A17249
    Quick View
    tyrosine kinase inhibitor
    Apatinib (YN968D1) is an orally bioavailable tyrosine kinase inhibitor, which selectively targets VEGFR-2 with an IC50 of 1 nM. 了解更多
  40. Niraparib tosylate

    Catalog No. A16618
    Quick View
    PARP1/PARP2 inhibitor
    Niraparib tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively. 了解更多
  41. Nav1.7-IN-3

    Catalog No. A13626
    Quick View
    voltage-gated sodium channel Nav1.7 inhibitor
    Nav1.7-IN-3 is a selective, orally bioavailable voltage-gated sodium channel Nav1.7 inhibitor with an IC50 of 8 nM. Pain relief. Limited CNS penetration. 了解更多
  42. Oseltamivir (acid)

    Catalog No. A11515
    Quick View
    influenza virus neuraminidase inhibitor
    Oseltamivir acid (GS 4071), the active metabolite of Oseltamivir phosphate, is an orally bioavailable, potent and selective inhibitor of influenza virus neuraminidase (IC50=2 nM) with activity against both influenza A and B viruses. 了解更多
  43. LX-1031

    Catalog No. A11479
    Quick View
    TPH inhibitor
    LX-1031 is a potent, orally available tryptophan 5-hydroxylase (TPH) inhibitor that reduces serotonin (5-HT) synthesis peripherally. 了解更多
  44. BOC-D-FMK

    Catalog No. A11356
    Quick View
    caspase inhibitor
    Boc-D-FMK is a cell-permeable, irreversible and broad spectrum caspase inhibitor; inhibits apoptosis stimulated by TNF-α with an IC50 of 39 ?M. 了解更多
  45. Cenisertib

    Catalog No. A11262
    Quick View
    multi-kinase inhibitor
    Cenisertib (AS-703569) is a multi-kinase inhibitor that blocks the activity of Aurora-kinase-A/B, ABL1, AKT, STAT5 and FLT3. 了解更多
  46. Calyculin A

    Catalog No. A11791
    Quick View
    PP2A inhibitor
    Calyculin A is a potent and cell-permeable protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) inhibitor with IC50s of 2 nM and 0.5-1 nM. 了解更多
  47. Histone Acetyltransferase Inhibitor II

    Catalog No. A12331
    Quick View
    cell permeable p300 inhibitor
    Histone Acetyltransferase Inhibitor II is a potent and cell permeable p300 inhibitor, with an IC50 of 5 ?M; Histone Acetyltransferase Inhibitor II can be used in cancer research. 了解更多
  48. RIPA-56

    Catalog No. A12473
    Quick View
    RIP1 inhibitor
    RIPA-56 is a highly potent, selective, and metabolically stable inhibitor of receptor-interacting protein 1 (RIP1) with an IC50 of 13 nM. 了解更多
  49. L-873724

    Catalog No. A12487
    Quick View
    Cathepsin K inhibitor
    L-873724 is a potent, orally bioavailable, selective and reversible non-basic cathepsin K inhibitor. 了解更多
  50. Edicotinib

    Catalog No. A13008
    Quick View
    CSF-1 receptor inhibitor
    Edicotinib is a selective and orally available colony-stimulating factor-1 (CSF-1) receptor inhibitor, and has entered phase IIA clinical trial to study rheumatoid arthritis (RA) despite disease. 了解更多

产品 51 到 100 共 176个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4

设置降序顺序
Rewards